15.04.2020Advent Life Sciences Continues Support of Innovation in Life Sciences with the Launch of Two New Cancer Companies

Press Release
15.04.2020PIC Therapeutics Raises $5 Million to Advance Development of Small Molecules That Selectively Modulate eIF4E

Press Release
08.04.2020Arrakis Therapeutics Enters Strategic Collaboration and License Agreement with Roche for Multi-Target Program Utilizing RNA-Targeted Small Molecule Drug Discovery Platform

Press Release
07.04.2020Amphista Therapeutics raises $7.5m Series A round to advance targeted protein degradation assets in cancer

Press Release
18.02.2020 New company takes aim at treatments for multiple sclerosis

Press Release
13.01.2020KaNDy Therapeutics Announces Positive Phase 2b Data in Post-Menopausal Women with its Lead Non-Hormonal Product NT-814

Press Release
22.12.2019Bioncotech Therapeutics Announces Oncology Clinical Trial Collaboration with MSD Phase II Trial

Press Release
14.11.2019Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System for Urinary Clinical Indications

Press Release
11.11.2019F2G Receives US FDA Breakthrough Therapy Designation for Olorofim

 

Press Release
09.09.2019Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System

 

Press Release